GC
MGCD

Globeflex Capital’s MGC Diagnostics Corporation MGCD Stock Holding History

Globeflex Capital’s Portfolio MGCD Stock Details MGCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-107
Closed -$1K – 619
2014
Q3 		$1K Sell
107
-34
-24% -$263 ﹤0.01% 523
2014
Q2 		$1K Sell
141
-30
-18% -$297 ﹤0.01% 566
2014
Q1 		$1K Hold
171
– – ﹤0.01% 583
2013
Q4 		$2K Hold
171
– – ﹤0.01% 477
2013
Q3 		$1K Buy
+171
New +$1.54K ﹤0.01% 571

Other funds holding MGCD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IM
ISF Management New York $47.4M AUM 6.56% 1-Year Est. Return
HIP
Hatteras Investment Partners Raleigh, North Carolina $169K AUM 86.49% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Globeflex Capital's MGCD Position: Q4 2014 in Review

Globeflex Capital sold out of MGC Diagnostics Corporation (MGCD) in Q4 2014, closing a stake of 107 shares — an estimated $1K sold.

Globeflex Capital first reported a position in MGCD in Q3 2013 and held it in 5 quarters. The position peaked at $2K in Q4 2013. 16 funds tracked by Wall St. Rank hold MGCD as of Q4 2014.

  • Globeflex Capital reported no remaining MGC Diagnostics Corporation position as of Q4 2014 after selling out during the quarter.
  • Globeflex Capital sold 107 MGC Diagnostics Corporation shares in Q4 2014, an estimated $1K.
  • Globeflex Capital first reported a position in MGC Diagnostics Corporation in Q3 2013 and held it in 5 quarters.
  • Globeflex Capital's MGC Diagnostics Corporation position peaked at $2K in Q4 2013.
  • 16 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q4 2014.

Based on Globeflex Capital's 13F filing for Q4 2014, filed 10 Feb 2015.